From: Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience
Tissue type
Osteosarcoma
60 ppm
Healthy muscle/bone
15 ppm
Skin
22.5 ppm
